News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 2153
- Sources here
- 16
- Companies here
- 18
Active search
2153 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
CRH (CRH) Stock May Be Fairly Valued After Utah Aggregates Deal
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. CRH has almost doubled shareholders' money over the past five years, yet recent weakness in the share price and a fairly valued Discounted …
Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV
This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …
Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock
An officer at Rhythm Pharmaceuticals (RYTM.US) recently sold a substantial amount of common stock, totaling US$8.9 million. This transaction indicates a significant insider sale for the company.
Markel Group Inc. Grows Stake in Weyerhaeuser Company $WY
Markel Group Inc. significantly increased its stake in Weyerhaeuser Company by 585.7% in the second quarter, now holding 120,000 shares valued at $2,873,000. Other institutional investors also adjusted their holdings in Weyerhaeuser, which saw its stock trading down slightly at $24.55. The company recently …
Levin Capital Strategies L.P. Invests $2.25 Million in Weyerhaeuser Company $WY
Levin Capital Strategies L.P. has acquired a new stake of 94,000 shares, valued at $2.25 million, in Weyerhaeuser Company (NYSE:WY) during the second quarter. Other institutional investors have also adjusted their holdings in the company. Wall Street analysts currently have a "Moderate Buy" rating …
Pictet Asset Management Holding SA Sells 570,173 Shares of Weyerhaeuser Company $WY
Pictet Asset Management Holding SA reduced its stake in Weyerhaeuser Company (NYSE:WY) by 11.8% in the second quarter, selling 570,173 shares, but still holds 4.28 million shares valued at over $102 million. Analysts maintain a "Moderate Buy" rating for Weyerhaeuser with an average price …
NewEdge Advisors LLC Raises Stake in Weyerhaeuser Company $WY
NewEdge Advisors LLC significantly increased its stake in Weyerhaeuser Company (NYSE:WY) by 317.4% in the first quarter, now holding 89,800 shares valued at $2.19 million. Institutional investors collectively own a substantial 82.99% of the company. Weyerhaeuser reported strong Q1 earnings, surpassing analyst estimates with …
Cambiar Investors LLC Purchases 55,769 Shares of Weyerhaeuser Company $WY
Cambiar Investors LLC increased its stake in Weyerhaeuser Company (NYSE:WY) by 5.3% in the second quarter, acquiring an additional 55,769 shares. This brings their total holdings to 1.10 million shares, valued at approximately $26.3 million. Weyerhaeuser also reported beating quarterly earnings expectations with adjusted …
Handelsbanken Fonder AB Reduces Stock Holdings in Weyerhaeuser Company $WY
Handelsbanken Fonder AB reduced its stake in Weyerhaeuser Company (NYSE:WY) by 17.9% in the second quarter, selling 48,885 shares and retaining 223,900 shares valued at $5.36 million. Despite the reduction, institutional investors collectively own 82.99% of Weyerhaeuser. The company reported strong quarterly earnings, beating …
Aberdeen Group plc Acquires 125,264 Shares of Weyerhaeuser Company $WY
Aberdeen Group plc increased its stake in Weyerhaeuser Company (NYSE:WY) by 13.8% in the second quarter, purchasing an additional 125,264 shares, bringing its total holdings to over 1 million shares valued at $24.7 million. Weyerhaeuser maintains a "Moderate Buy" consensus rating with an average …
Weyerhaeuser Company $WY Shares Purchased by AIA Group Ltd
AIA Group Ltd significantly increased its stake in Weyerhaeuser Company (NYSE:WY) by 92.4% in the second quarter, acquiring an additional 343,414 shares, bringing its total to 714,991 shares valued at $17.1 million. The article notes that institutional investors own a substantial 82.99% of WY …
Liquidity Mapping Around (RBKB) Price Events
This article from Stock Traders Daily discusses liquidity mapping around price events for Rhinebeck Bancorp Inc. (NASDAQ: RBKB). It highlights a near-term strong sentiment influencing mid-term neutrality toward a long-term positive bias, despite elevated downside risk. The analysis provides specific trading strategies (Position, Momentum …
Rhinebeck Bancorp names Jamie Bloom and Kevin Nihill as vested participants after plan termination
Rhinebeck Bancorp has terminated its Executive Long-Term Incentive and Retention Plan, resulting in the full vesting of accounts for participants Jamie Bloom and Kevin Nihill, effective May 19, 2026. Both individuals were named executive officers and participants in the previously established plan. This change …
Insider Selling: Rhythm Pharmaceuticals (NASDAQ:RYTM) EVP Sells 75,834 Shares of Stock
Rhythm Pharmaceuticals' EVP, Jennifer Kayden Lee, sold 75,834 shares of the company's stock for approximately $8.9 million, reducing her ownership by 58.3%. This transaction occurred under a pre-arranged Rule 10b5-1 trading plan. The company's stock is trading near its 52-week high, and analysts maintain …
Weyerhaeuser Co To Go Ex-Dividend On September 4th, 2026 With 0.21 USD Dividend Per Share
Weyerhaeuser Co (WY) is scheduled to go ex-dividend on September 4th, 2026, with a dividend payment of $0.21 per share. Investors wishing to receive this dividend must own shares before the ex-dividend date.
Rhythm Pharmaceuticals EVP, Jennifer Lee, sells $8.9m in stock
Jennifer Lee, EVP of Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM), sold approximately $8.9 million worth of common stock after exercising options for about $997,036. The sale was executed under a Rule 10b5-1 trading plan as the stock trades near its 52-week high and is considered overvalued …
Rhythm Pharmaceuticals (RYTM) EVP exercises 56,601 options and sells 75,834 shares
Jennifer Kayden Lee, EVP of Rhythm Pharmaceuticals (RYTM), exercised 56,601 stock options at prices of $24.29 and $6.80, and subsequently sold 75,834 common shares at $117.3818 per share. These transactions, valued at approximately $8.90 million gross proceeds from sales and $997K in exercise costs, …
Algorhythm Holdings Releases Q2 2026 Financial Results
Algorhythm Holdings (NASDAQ: MICS) reported a net loss of $4.1 million for Q2 2026, or $0.25 per share, an increase from the $0.24 loss per share in Q2 2025, due to heavy investment in growth. Despite the widening loss, revenue surged by 161% to …
Weyerhaeuser Co. stock underperforms Friday when compared to competitors
Weyerhaeuser Co. (WY) shares fell 1.05% on Friday, closing at $24.56, despite a broader market decline for the S&P 500 and Dow Jones Industrial Average. The stock is now 11.50% below its 52-week high of $27.75, which was reached on February 12th.
Rhinebeck Bancorp (RBKB) terminates executive long-term deferred compensation plan
Rhinebeck Bancorp (RBKB) announced the termination of its Rhinebeck Bank Executive Long-Term Incentive and Retention Plan, a non-qualified deferred compensation plan, on May 19, 2026. The termination resulted in the immediate vesting of account balances for participating officers, including Jamie Bloom and Kevin Nihill. …
Algorhythm Holdings earnings beat by $0.54, revenue topped estimates
Algorhythm Holdings (NASDAQ: RIME) reported second-quarter EPS of $-0.2500, significantly surpassing analyst estimates of $-0.7900 by $0.54. The company's revenue for the quarter also exceeded expectations, coming in at $3.01 million against a consensus estimate of $3 million. Despite the strong earnings beat, Algorhythm …